DNA SEQUENCING/GENOTYPING CORE FACILITY

DNA 测序/基因分型核心设施

基本信息

项目摘要

DESCRIPTION: (Applicant's Description) The overall objective of this proposal is to transform the current Department of Human Genetics DNA Sequencing Core into an Institution-wide, state-of-the-art, high-quality sequencing, genotyping, and loss of heterozygosity (LOH) shared resource to advance cancer-related and other research at the Mount Sinai School of Medicine. With this grant application and a significant Institutional commitment for capital equipment purchases, this Core will be upgraded and enhanced to provide these services to all NCI-funded, NIH-funded, and other Investigators at Mount Sinai. Throughput will be greatly increased and Core services will be highly accessible to cancer-oriented and other research efforts. The Core will provide in-house expertise and consultation services for all sequencing, genotyping, and LOH projects. This Core will meet the intense needs of cancer and other researchers for on-site sequencing to speed gene discovery, gene structure analysis, mutation characterization, analysis of vector constructs, etc. Since most cancers have an underlying genetic susceptibility factor, a high-throughput facility for the identification of human genetic variation in the form of haplotype differences is invaluable for cancer-gene discovery. Frequent quality control assessments will be used to validate the accuracy, quality and throughput of all Core services. The Core will provide educational opportunities to the Mount Sinai community through minicourses, presentations and workshops. The goal is to encourage use of Core resources to further reduce costs for cancer-related and other research at Mount Sinai. In addition to the visibility gained by the educational efforts of the Core, investigator awareness of the availability and features of Core services will be promulgated through creation of a Website, campus-wide E-mail announcements and a biannual newsletter. The Core will also evaluate and implement new, protocols, upgrades and technology to meet the ever changing and expanding needs of modern biomedical research. Importantly, equitable, cost-effective and responsive Core services will be promoted through the establishment of an Institutional Advisory Committee. This multidisciplinary committee will provide oversight and coordination of Core services. They will review costs and income regularly and annually adjust prices to achieve the greatest possible savings to investigators. They will also identify and recommend novel strategies, technologies, instrumentation, and resources to further facilitate and foster cutting-edge cancer and other research.
描述:(申请人描述)本提案的总体目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID Franklin BISHOP其他文献

DAVID Franklin BISHOP的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID Franklin BISHOP', 18)}}的其他基金

Illumina Genome Analyzer II
Illumina 基因组分析仪 II
  • 批准号:
    7595397
  • 财政年份:
    2009
  • 资助金额:
    $ 19.78万
  • 项目类别:
ABI 3730XL DNA ANALYZER: GENOMICS
ABI 3730XL DNA 分析仪:基因组学
  • 批准号:
    7335253
  • 财政年份:
    2006
  • 资助金额:
    $ 19.78万
  • 项目类别:
DNA ANALYZER: RARE DIS: NOONAN SYND, FARBER, NIEMANN-PICK, PHENYLKETONURIA DIS
DNA 分析仪:稀有​​ DIS:NOONAN SYND、FARBER、NIEMANN-PICK、苯丙酮尿症 DIS
  • 批准号:
    7335252
  • 财政年份:
    2006
  • 资助金额:
    $ 19.78万
  • 项目类别:
ABI 3730XL DNA ANALYZER: HIV-ASSOCIATED NEPHROPATHY
ABI 3730XL DNA 分析仪:HIV 相关肾病
  • 批准号:
    7335249
  • 财政年份:
    2006
  • 资助金额:
    $ 19.78万
  • 项目类别:
ABI 3730XL DNA ANALYZER: INFLUENZA VIRUS
ABI 3730XL DNA 分析仪:流感病毒
  • 批准号:
    7335251
  • 财政年份:
    2006
  • 资助金额:
    $ 19.78万
  • 项目类别:
ABI 3730xl DNA Analyzer
ABI 3730xl DNA 分析仪
  • 批准号:
    7046516
  • 财政年份:
    2006
  • 资助金额:
    $ 19.78万
  • 项目类别:
ABI 3730XL DNA ANALYZER: BREAST CANCER, AGING AND CANCER, CARCINOMA
ABI 3730XL DNA 分析仪:乳腺癌、衰老和癌症、癌症
  • 批准号:
    7335250
  • 财政年份:
    2006
  • 资助金额:
    $ 19.78万
  • 项目类别:
High-Throughput Robotic Liquid Handling System
高通量机器人液体处理系统
  • 批准号:
    6580965
  • 财政年份:
    2003
  • 资助金额:
    $ 19.78万
  • 项目类别:
DNA SEQUENCING/GENOTYPING CORE FACILITY
DNA 测序/基因分型核心设施
  • 批准号:
    6514753
  • 财政年份:
    2001
  • 资助金额:
    $ 19.78万
  • 项目类别:
HIGH THROUGHPUT DNA SEQUENCING/GENTOYPING SYSTEM
高通量 DNA 测序/基因分型系统
  • 批准号:
    6292422
  • 财政年份:
    2001
  • 资助金额:
    $ 19.78万
  • 项目类别:

相似海外基金

BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3819816
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    4691285
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3815902
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY EQUIPMENT
生物医学设施设备
  • 批准号:
    3931637
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3961763
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3811789
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3937887
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    4690608
  • 财政年份:
  • 资助金额:
    $ 19.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了